Myosana Therapeutics
PrivateLast Round
Crowdfunding
Jun 3, 2025
Est. Valuation
$27.38M
Total Funding Raised
$6.95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Myosana Therapeutics operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Crowdfunding round in June 2025.
Myosana Therapeutics is a biotechnology company that develops a muscle-specific non-viral gene therapy platform for the treatment of neuromuscular and cardiac diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myosana Therapeutics Comparables
Compare Myosana Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spot Biosystems | 88% | |
| Orphina Biotechnology | 86% | |
| Kinea Bio, Inc. | 81% |
For institutional investors. Book with your work email.
Myosana Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jun 3, 2025 | ||||
| Seed | Jan 25, 2023 | ||||
| Grant | Aug 26, 2021 | ||||
| Seed | Apr 22, 2020 |
For institutional investors. Book with your work email.
Myosana Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CureDuchenne Ventures | Seed, Crowdfunding |
| Parent Project Muscular Dystrophy | Grant, Seed, Crowdfunding |
| Muscular Dystrophy Association | Seed, Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 150% MoM.
- May 13, 2026
Monthly visitors increased 37% MoM.
For institutional investors. Book with your work email.
Myosana Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Myosana Therapeutics's valuation, stock price, and market status.
Is Myosana Therapeutics a public or private company?
Myosana Therapeutics is a private company.
What is the current stock price of Myosana Therapeutics?
Myosana Therapeutics is a private company, so its shares have no public market price. Caplight tracks Myosana Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Myosana Therapeutics worth (valuation)?
Myosana Therapeutics's valuation is estimated at $27.4M based on funding round data.
Can I buy Myosana Therapeutics stock?
Myosana Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Myosana Therapeutics's last funding round?
Myosana Therapeutics's most recent funding round was Crowdfunding on June 3, 2025.
Who are the main investors in Myosana Therapeutics?
Key investors in Myosana Therapeutics include CureDuchenne Ventures.
Will Myosana Therapeutics IPO soon?
No public IPO plans have been announced for Myosana Therapeutics.
How can I track Myosana Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Myosana Therapeutics's shares on secondary markets.